Ongoing Securities Investigation into Mereo BioPharma Group plc (MREO) - Contact Levi & Korsinsky
Mereo BioPharmaMereo BioPharma(US:MREO) TMX Newsfile·2026-01-14 14:34

New York, New York--(Newsfile Corp. - January 14, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Mereo BioPharma Group plc ("Mereo BioPharma Group plc") (NASDAQ: MREO) concerning potential violations of the federal securities laws.On December 29, 2025, before the market opened, Mereo announced results from its Phase 3 ORBIT and COSMIC studies for setrusumab (UX143) in Osteogenesis Imperfecta (OI). The company reported that neither study failed to achieve its primary ...